Ultragenyx appoints Howard Horn as CFO and EVP, Corporate Strategy effective Oct 16, 2023

Ultragenyx Pharmaceutical Inc.

Howard Horn appointed CFO and EVP, Corporate Strategy effective October 16, 2023.
Base salary of $590,000/year, target bonus 50%, sign-on bonus of $60,000.
Equity award with target value of $6 million: 50% options, 50% RSUs vesting over 4 years.
Previously CFO at Vir Biotechnology (2017-2023) and held finance roles at Biogen.
Will lead finance, accounting, corporate strategy, and investor relations at Ultragenyx.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Howard Horn

Chief Financial Officer and Executive Vice President, Corporate Strategy

RARE · Ultragenyx Pharmaceutical Inc.

Effective: 2023-10-16
Filed: July 12, 2023, 7:59 PM ET

On July 12, 2023, Ultragenyx Pharmaceutical Inc. (the “Company”) announced that Howard Horn has been appointed as the Company’s Chief Financial Officer and Executive Vice President, Corporate Strategy, effective as of October 16, 2023

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Howard Horn was appointed as Chief Financial Officer and Executive Vice President, Corporate Strategy at Ultragenyx Pharmaceutical Inc..

Action: appointed
Role: Chief Financial Officer and Executive Vice President, Corporate Strategy

Exact text from the filing

On July 12, 2023, Ultragenyx Pharmaceutical Inc. (the “Company”) announced that Howard Horn has been appointed as the Company’s Chief Financial Officer and Executive Vice President, Corporate Strategy, effective as of October 16, 2023

View on SEC.gov

Ultragenyx Pharmaceutical Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-032604

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.